ANI Pharmaceuticals has named Cipla USA chief executive Nikhil Lalwani to become its new president and CEO from 8 September. Lalwani – who will join ANI’s board on the same date – will replace interim president and CEO Patrick Walsh, who had stepped in after the departure of former chief Arthur Przybyl earlier this year. (Also see "ANI Names Interim CEO As Przybyl Prepares To Step Down" - Generics Bulletin, 8 May, 2020.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?